Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia Article

Chen, C, Deslouches, B, Montelaro, RC et al. (2018). Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia . 24(5), 10.1016/j.cmi.2017.08.029

cited authors

  • Chen, C; Deslouches, B; Montelaro, RC; Di, YP

authors

publication date

  • May 1, 2018

keywords

  • Antibiotic resistance
  • Antimicrobial peptides
  • BAD BUGS
  • CELLS
  • CYSTIC-FIBROSIS PATIENTS
  • Cationic peptides
  • HOST-DEFENSE
  • INFECTION
  • Infectious Diseases
  • LL37
  • LUNG
  • Life Sciences & Biomedicine
  • MOLECULAR EPIDEMIOLOGY
  • Microbiology
  • PSEUDOMONAS-AERUGINOSA
  • Pneumonia
  • Pseudomonas aeruginosa
  • Resistance
  • Respiratory infection
  • Science & Technology
  • TRYPTOPHAN
  • VENTILATOR-ASSOCIATED PNEUMONIA
  • WLBU2

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCI LTD

volume

  • 24

issue

  • 5